Triptolide suppresses alkali burn ‐induced corneal angiogenesis along with a downregulation of VEGFA and VEGFC expression

In conclusion, topical TPL as a pharmacological agent has the ability to reduce angiogenesis in cornea and may have clinical indications for the treatment of corneal angiogenesis diseases which have to be further explored. This article is protected by copyright. All rights reserved.
Source: The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology - Category: Molecular Biology Authors: Tags: Full Length Article Source Type: research